First Citizens Bank & Trust Boosts Eli Lilly Holdings by 58.8% to 24,634 Shares
First Citizens Bank & Trust Co increased its Eli Lilly stake by 58.8% in Q3, acquiring an additional 9,121 shares to hold 24,634 total. The new position was valued at $18.8 million as of its latest 13F filing.
1. First Citizens Bank Lifts Stake by 58.8%
First Citizens Bank & Trust Co. reported in its latest 13F filing that it acquired an additional 9,121 shares of Eli Lilly during the third quarter, bringing its total holding to 24,634 shares. The new position is valued at approximately $18.8 million, reflecting the bank’s increased conviction in Lilly’s late-stage pipeline and recent sales growth across key therapeutic areas.
2. Institutional Ownership Remains Elevated
Eli Lilly’s stock is held 82.53% by institutional investors, a level supported by active adjustments from both global and boutique funds. Sumitomo Mitsui Financial Group initiated a $27,000 stake in Q2, Steph & Co. expanded its position by 290% to 39 shares, and Bare Financial Services lifted its holding by 263.6% to 40 shares. This broad engagement underscores the company’s appeal amid strong earnings, robust ROE of 109.5%, and a diversified global footprint.